1653303769_29bONT_Divis.jpeg 
Revenue from operations rose to Rs 2,518 crore for the fourth quarter ended on March 31, 2022, as against Rs 1,788 crore in the year-ago period
Photo Credit :
Divi's Laboratories on Monday said its consolidated net profit increased by 78 per cent to Rs 895 crore in the quarter ended on March 31, 2022.
The drug maker had reported a net profit of Rs 502 crore in the January-March quarter of 2020-21 fiscal.
Revenue from operations rose to Rs 2,518 crore for the fourth quarter ended on March 31, 2022, as against Rs 1,788 crore in the year-ago period, Divi's Laboratories said in a regulatory filing. For the year ended in March 2022, the company posted a consolidated net profit of Rs 2,960 crore as against Rs 1,984 crore in FY21.
Revenue from operations rose to Rs 8,960 crore as compared with Rs 6,969 crore in 2020-21.
The company said its board has recommended a dividend of Rs 30 per share of face value Rs 2 (1,500 per cent) for 2021-22, subject to approval of members at the ensuing annual general meeting.
Shares of the company were trading 6.37 per cent down at Rs 4,032.35 apiece on the BSE.